CLINICAL_TRIALS
trial_result
· 2018-04-03
Clinical Trial Update: HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH [NA]
Summary
Completed trial evaluating HoLEP at 50W versus 100W for benign prostatic hyperplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Mansoura University | Conditions: Prostatic Hyperplasia | NA | Status: COMPLETED